tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BIIB Stock Latest News

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
Press ReleasesUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
14h ago
BIIB
Sage Therapeutics, Biogen report results from Phase 2 study of SAGE-324
PremiumThe Fly
Sage Therapeutics, Biogen report results from Phase 2 study of SAGE-324
3d ago
BIIB
SAGE
Wedbush reveals three potential buyout targets for Biogen
PremiumThe Fly
Wedbush reveals three potential buyout targets for Biogen
10d ago
BIIB
EWTX
Ionis Pharmaceuticals price target raised to $67 from $64 at BofA
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $67 from $64 at BofA
11d ago
BIIB
IONS
Biogen price target lowered to $313 from $335 at Piper Sandler
PremiumThe Fly
Biogen price target lowered to $313 from $335 at Piper Sandler
15d ago
BIIB
Biogen reports Leqembi approved for treatment of Alzheimer’s in Israel
PremiumThe FlyBiogen reports Leqembi approved for treatment of Alzheimer’s in Israel
15d ago
BIIB
Biogen price target lowered to $311 from $331 at Morgan Stanley
PremiumThe Fly
Biogen price target lowered to $311 from $331 at Morgan Stanley
16d ago
BIIB
Biogen announces Hong Kong has approved Leqembi to treat Alzheimer’s
PremiumThe Fly
Biogen announces Hong Kong has approved Leqembi to treat Alzheimer’s
16d ago
BIIB
AI Could Revolutionize Drug Discovery: A Look at Key Players 
PremiumMarket News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
18d ago
GS
TAK
Eisai downgraded to Neutral from Buy at BofA
PremiumThe Fly
Eisai downgraded to Neutral from Buy at BofA
23d ago
LLY
BIIB
Class Action Lawsuit against Biogen, Inc. (NASDAQ:BIIB)
PremiumMarket News
Class Action Lawsuit against Biogen, Inc. (NASDAQ:BIIB)
24d ago
BIIB
Biogen down 2% after Eli Lilly gets FDA approval for Alzheimer’s drug
PremiumThe Fly
Biogen down 2% after Eli Lilly gets FDA approval for Alzheimer’s drug
24d ago
LLY
BIIB
Biogen completes acquisition of Human Immunology Biosciences
PremiumThe FlyBiogen completes acquisition of Human Immunology Biosciences
24d ago
BIIB
Biogen Completes Acquisition of Human Immunology Biosciences
PremiumPress Releases
Biogen Completes Acquisition of Human Immunology Biosciences
24d ago
BIIB
Biogen’s Lecanemab launched in China to treat Alzheimer’s Disease
PremiumThe Fly
Biogen’s Lecanemab launched in China to treat Alzheimer’s Disease
29d ago
BIIB
Biogen’s Lecanemab launched in China to treat Alzheimer’s Disease Use symbol Eisai
PremiumThe Fly
Biogen’s Lecanemab launched in China to treat Alzheimer’s Disease Use symbol Eisai
29d ago
BIIB
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
PremiumPress Releases
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
29d ago
BIIB
RBC believes Leqembi on track for EU approval after speaking to Biogen
PremiumThe Fly
RBC believes Leqembi on track for EU approval after speaking to Biogen
1M ago
BIIB
Biogen announces Tofidence biosimilar approved in European Union
PremiumThe Fly
Biogen announces Tofidence biosimilar approved in European Union
1M ago
BIIB
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
PremiumPress ReleasesTOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
1M ago
BIIB
Eli Lilly Stock (LLY) Gained on FDA Panel Approval
PremiumMarket News
Eli Lilly Stock (LLY) Gained on FDA Panel Approval
2M ago
LLY
BIIB
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
PremiumPress Releases
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
2M ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >